National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
NCT Number: NCT00001627
This study is designed to provide bone marrow and/or blood cells for other research studies. Patients participating in this study will be asked to provide small amounts of medical information and undergo a limited physical examination designed to detect the presence of any obvious blood disease. A blood and bone marrow sample will be obtained to verify that the patient has normal blood cell production.
Researchers plan to obtain bone marrow samples to be used in laboratory studies directed toward understanding the formation of blood cells. Bone marrow samples will be taken from the hip bone of patients and healthy volunteers.
These samples are valuable to many research studies within the Hematology Branch of the National Heart, Lung, and Blood Institute, including studies of normal and abnormal production of blood cells, the viral causes of blood diseases, and the role of the immune system in bone marrow failure and related conditions....
Looking for future studies?
Notify Me2 year–110 year
All sexes
Observational
Bethesda, Maryland, 20892, United States
This protocol defines in general terms the purposes for which blood and bone marrow specimens will be collected by members of the Hematology Branch and the conditions under which the sampling will be performed. Samples of blood and bone marrow from healthy volunteers and from patients are indispensable for many research projects, including studies of normal and abnormal hematopoiesis, the viral etiology of blood diseases, and the role of the immune system in marrow failure and related conditions.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Healthy volunteers age greater than or equal to 18 years.
Subjects with hematologic disease age greater than or equal to 2 (for subjects less than 18, blood and bone marrow specimens will be obtained concurrently with clinically indicated sampling).
Exclusion criteria
History of a significant bleeding disorder.
Abnormal host-defense mechanisms.
Time frame: Ongoing
The collection of adequate cells for laboratory research.
National Heart, Lung, and Blood Institute (NHLBI)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03066648
Bone Marrow Diseases, Chronic Disease
Boston, Massachusetts, United States
View Trial DetailsNCT00085670
Bone Diseases, Bone Diseases, Developmental
Bethesda, Maryland, United States
View Trial DetailsNCT01787552
Blood Coagulation Disorders, Blood Platelet Disorders
Camperdown, New South Wales, Australia
View Trial DetailsNCT01629082
Acute Myeloid Leukemia (AML), Agranulocytosis
Bethesda, Maryland, United States
View Trial Details